|
1
|
Zhang ZF, Zhang HR, Zhang QY, Lai SY, Feng
YZ, Zhou Y, Zheng SR, Shi R and Zhou JY: High expression of TMEM40
is associated with the malignant behavior and tumorigenesis in
bladder cancer. J Transl Med. 16:92018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Czerniak B, Dinney C and McConkey D:
Origins of bladder cancer. Ann Rev Pathol. 11:149–174. 2016.
View Article : Google Scholar
|
|
4
|
Burger M, Catto JW, Dalbagni G, Grossman
HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C,
Shariat S and Lotan Y: Epidemiology and risk factors of urothelial
bladder cancer. Eur Urol. 63:234–241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mao W, Huang X, Wang L, Zhang Z, Liu M, Li
Y, Luo M, Yao X, Fan J and Geng J: Circular RNA hsa_circ_0068871
regulates FGFR3 expression and activates STAT3 by targeting
miR-181a-5p to promote bladder cancer progression. J Exp Clin
Cancer Res. 38:1692019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Babjuk M, Oosterlinck W, Sylvester R,
Kaasinen E, Böhle A and Palou-Redorta J; European Association of
Urology (EAU), : EAU guidelines on non-muscle-invasive urothelial
carcinoma of the bladder. Eur Urol. 54:303–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gupta NP, Goel R, Hemal AK, Dogra PN, Seth
A, Aron M, Kumar R and Ansari MS: Radical cystectomy in
septuagenarian patients with bladder cancer. Int Urol Nephrol.
36:353–358. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alfred Witjes J, Lebret T, Comperat EM,
Cowan NC, De Santis M, Bruins HM, Hernández V, Espinós EL, Dunn J,
Rouanne M, et al: Updated 2016 EAU guidelines on muscle-invasive
and metastatic bladder cancer. Eur Urol. 71:462–475. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Konety BR, Joslyn SA and O'Donnell MA:
Extent of pelvic lymphadenectomy and its impact on outcome in
patients diagnosed with bladder cancer: Analysis of data from the
surveillance, epidemiology and end results program data base. J
Urol. 169:946–950. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siemens DR, Mackillop WJ, Peng Y, Wei X,
Berman D and Booth CM: Lymph node counts are valid indicators of
the quality of surgical care in bladder cancer: A population-based
study. Urol Oncol. 33:e415–e423. 2015. View Article : Google Scholar
|
|
11
|
May M, Herrmann E, Bolenz C, Tiemann A,
Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C,
Wülfing C, et al: Lymph node density affects cancer-specific
survival in patients with lymph node-positive urothelial bladder
cancer following radical cystectomy. Eur Urol. 59:712–718. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Herr H, Lee C, Chang S and Lerner S;
Bladder Cancer Collaborative G, : Standardization of radical
cystectomy and pelvic lymph node dissection for bladder cancer: A
collaborative group report. J Urol. 171:1823–1828. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hedgepeth RC, Zhang Y, Skolarus TA and
Hollenbeck BK: Variation in use of lymph node dissection during
radical cystectomy for bladder cancer. Urology. 77:7720112011.
View Article : Google Scholar
|
|
14
|
Simone G, Papalia R, Ferriero M,
Guaglianone S, Castelli E, Collura D, Muto G and Gallucci M:
Stage-specific impact of extended versus standard pelvic lymph node
dissection in radical cystectomy. Int J Urol. 20:390–397. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bruins HM, Veskimae E, Hernandez V,
Imamura M, Neuberger MM, Dahm P, Stewart F, Lam TB, N'Dow J, van
der Heijden AG, et al: The impact of the extent of lymphadenectomy
on oncologic outcomes in patients undergoing radical cystectomy for
bladder cancer: A systematic review. Eur Urol. 66:1065–1077. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cole AP, Dalela D, Hanske J, Mullane SA,
Choueiri TK, Meyer CP, Nguyen PL, Menon M, Kibel AS, Preston MA, et
al: Temporal trends in receipt of adequate lymphadenectomy in
bladder cancer 1988 to 2010. Urol Oncol. 33:e509–e517. 2015.
View Article : Google Scholar
|
|
17
|
Maruf M, Sidana A, Purnell S, Jain AL,
Brancato SJ and Agarwal PK: Lymph node dissection during radical
cystectomy following prior radiation therapy: Results from the SEER
database. Int Urol Nephrol. 50:257–262. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gschwend JE, Heck MM, Lehmann J, Rübben H,
Albers P, Wolff JM, Frohneberg D, de Geeter P, Heidenreich A,
Kälble T, et al: Extended versus limited lymph node dissection in
bladder cancer patients undergoing radical cystectomy: Survival
results from a prospective, randomized trial. Eur Urol. 75:604–611.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mao W, Ma B, Huang X, Gu S, Luo M, Fan J
and Geng J: Which treatment is best for patients with AJCC stage IV
bladder cancer? Int Urol Nephrol. 51:1145–1156. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Compton CC, Byrd DR, Garciaaguilar J,
Kurtzman SH and Olawaiye A: AJCC Cancer Staging Atlas. Springer.
(Berlin). 2012. View Article : Google Scholar
|
|
21
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Leissner J, Hohenfellner R, Thuroff JW and
Wolf HK: Lymphadenectomy in patients with transitional cell
carcinoma of the urinary bladder; significance for staging and
prognosis. BJU Int. 85:817–823. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
von Landenberg N, Speed JM, Cole AP,
Seisen T, Lipsitz SR, Gild P, Menon M, Kibel AS, Roghmann F, Noldus
J, et al: Impact of adequate pelvic lymph node dissection on
overall survival after radical cystectomy: A stratified analysis by
clinical stage and receipt of neoadjuvant chemotherap. Urol Oncol.
36:e13–e78. 2018. View Article : Google Scholar
|
|
24
|
Stabile A, Muttin F, Zamboni S, Moschini
M, Gandaglia G, Fossati N, Dell'Oglio P, Capitanio U, Cucchiara V,
Mazzone E, et al: Therapeutic approaches for lymph node involvement
in prostate, bladder and kidney cancer. Expert Rev Anticancer Ther.
19:739–755. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee EK, Herr HW, Dickstein RJ, Kassouf W,
Munsell MF, Grossman HB, Dinney CP and Kamat AM: Lymph node density
for patient counselling about prognosis and for designing clinical
trials of adjuvant therapies after radical cystectomy. BJU Int.
110:E590–E595. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sharma M, Goto T, Yang Z and Miyamoto H:
The impact of perivesical lymph node metastasis on clinical
outcomes of bladder cancer patients undergoing radical cystectomy.
BMC Urol. 19:772019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Perera M, McGrath S, Sengupta S, Crozier
J, Bolton D and Lawrentschuk N: Pelvic lymph node dissection during
radical cystectomy for muscle-invasive bladder cancer. Nat Rev
Urol. 15:686–692. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Herr HW, Bochner BH, Dalbagni G, Donat SM,
Reuter VE and Bajorin DF: Impact of the number of lymph nodes
retrieved on outcome in patients with muscle invasive bladder
cancer. J Urol. 167:1295–1298. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dhar NB, Klein EA, Reuther AM, Thalmann
GN, Madersbacher S and Studer UE: Outcome after radical cystectomy
with limited or extended pelvic lymph node dissection. J Urol.
179:873–878. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Abol-Enein H, Tilki D, Mosbah A, El-Baz M,
Shokeir A, Nabeeh A and Ghoneim MA: Does the extent of
lymphadenectomy in radical cystectomy for bladder cancer influence
disease-free survival? A prospective single-center study. Eur Urol.
60:572–577. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Poulsen AL, Horn T and Steven K: Radical
cystectomy: Extending the limits of pelvic lymph node dissection
improves survival for patients with bladder cancer confined to the
bladder wall. J Urol. 160:2015–2019. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Koppie TM, Vickers AJ, Vora K, Dalbagni G
and Bochner BH: Standardization of pelvic lymphadenectomy performed
at radical cystectomy: Can we establish a minimum number of lymph
nodes that should be removed? Cancer. 107:2368–2374. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Herr HW: Extent of surgery and pathology
evaluation has an impact on bladder cancer outcomes after radical
cystectomy. Urology. 61:105–108. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Masson-Lecomte A, Vordos D, Hoznek A, Yiou
R, Allory Y, Abbou CC, de la Taille A and Salomon L: External
validation of extranodal extension and lymph node density as
predictors of survival in node-positive bladder cancer after
radical cystectomy. Ann Surg Oncol. 20:1389–1394. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Crump K: The potential effects of recall
bias and selection bias on the epidemiological evidence for the
carcinogenicity of glyphosate. Risk Anal. 30:134402019.
|
